In 2021, Zhang et al. showed that adipocyte-specific transferrin receptor deficiency, achieved through genetic modification, protected mice from high-fat, diet-induced metabolic disorders by restricting lipid absorption from the intestine through modulation of vesicular transport in enterocytes [33]. The gene discussed is TFRC; the disease is Other metabolic disease.